Dow Down 0.17% Nasdaq Down 0.28%

Genetic Technologies Limited (GENE)

-NasdaqCM
0.57 0.00(0.02%) Sep 30, 3:57PM EDT
Prev Close:0.57
Open:0.60
Bid:0.30 x 6900
Ask:0.69 x 200
1y Target Est:2.50
Beta:-0.63
Next Earnings Date:N/A
Day's Range:0.56 - 0.60
52wk Range:0.50 - 2.46
Volume:31,725
Avg Vol (3m):272,159
Market Cap:12.28M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GENEUp 0.02%12.28M
ABT62.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.39
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback